|
2016 Journal Article Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative studyKay, Margaret, Wijayanayaka, Shanika, Cook, Harriet and Hollingworth, Samantha (2016). Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study. British Journal of General Practice, 66 (647), E397-E409. doi: 10.3399/bjgp16X685249 |
|
2016 Journal Article Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetesMayfield, Karla, Siskind, Dan, Winckel, Karl, Russell, Anthony W., Kisely, Steve, Smith, Greg and Hollingworth, Samantha (2016). Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes. Journal of Psychopharmacology, 30 (3), 227-236. doi: 10.1177/0269881115625496 |
|
2016 Conference Publication Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits SchemeMcGrath, Alexandria, Sandhu, Geeta, McCaffrey, Elizabeth, Walpole, Euan, McKavanagh, Daniel and Hollingworth, Samantha (2016). Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15–17 November 2016. United Kingdom: Wiley-Blackwell . doi: 10.1111/ajco.12646 |
|
2016 Conference Publication Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparisonKairuz, Therese, Truter, Ilse, Pudmenzky, Alex, Fredericks, Ian, Rossato, Laurence and Hollingworth, Samantha (2016). Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison. 2nd Medicines Utilisation Research in Africa Symposium, Gaborone, Botswana, 25-27 July 2016. |
|
2016 Conference Publication Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014Ellen, Donges, Christine, Staatz, Paul, Kubler, Helen, Benham and Samantha, Hollingworth (2016). Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014. *, *, *. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Journal Article A review of medication use as an indicator of human health impact in environmentally stressed areasHollingworth, Samantha A., Kim, Diane Dabok and Jagals, Paul (2016). A review of medication use as an indicator of human health impact in environmentally stressed areas. Annals of Global Health, 82 (1), 111-118. doi: 10.1016/j.aogh.2016.01.010 |
|
2016 Conference Publication Does consumer medicines interest reflect medicines use?McGuire, T. M., Pache, D. M., van Driel, M. L. and Hollingworth, S. A. (2016). Does consumer medicines interest reflect medicines use?. Annual Conference of Australasian Pharmaceutical Science Association, Sydney University, Sydney, NSW, 2-5 December 2016. |
|
2015 Journal Article Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacyFredericks, Ian, Hollingworth, Samantha, Pudmenzky, Alex, Rossato, Laurence, Syed, Shahzad and Kairuz, Therese (2015). Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy. International Journal of Clinical Pharmacy, 37 (6), 1213-1221. doi: 10.1007/s11096-015-0188-y |
|
2015 Conference Publication Lenalidomide Use in Relapsed or Refractory Multiple Myeloma Patients At Five Large Queensland Public HospitalsMcKavanagh, Daniel, Walpole, Euan, Hollingworth, Samantha, Sharkey, Megan and Mollee, Peter (2015). Lenalidomide Use in Relapsed or Refractory Multiple Myeloma Patients At Five Large Queensland Public Hospitals. HOBOKEN: WILEY-BLACKWELL. |
|
2015 Journal Article Dopamine agonists: time pattern of adverse effects reporting in AustraliaHollingworth, Samantha A., McGuire, Treasure M., Pache, David and Eadie, Mervyn J. (2015). Dopamine agonists: time pattern of adverse effects reporting in Australia. Drugs - Real World Outcomes, 2 (3), 199-203. doi: 10.1007/s40801-015-0028-3 |
|
2015 Journal Article Opioid analgesic prescribing in Australia: a focus on gender and ageHollingworth, Samantha A., Gray, Paul D., Hall, Wayne D. and Najman, Jake M. (2015). Opioid analgesic prescribing in Australia: a focus on gender and age. Pharmacoepidemiology and Drug Safety, 24 (6), 628-636. doi: 10.1002/pds.3767 |
|
2015 Journal Article Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013Forrester, T., Siskind, D., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013. Pharmacopsychiatry, 48 (4-5), 164-169. doi: 10.1055/s-0035-1554713 |
|
2015 Journal Article Clozapine-induced myocarditis: separating the wheat from the chaffWinckel, Karl, Siskind, Dan, Hollingworth, Samantha and Wheeler, Amanda (2015). Clozapine-induced myocarditis: separating the wheat from the chaff. Australian and New Zealand Journal of Psychiatry, 49 (2), 188-188. doi: 10.1177/0004867414554269 |
|
2015 Journal Article Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trialMayfield, Karla, Siskind, Dan, Winckel, Karl, Hollingworth, Samantha, Kisely, Steve and Russell, Anthony W. (2015). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial. BJPsych Open, 1 (1), 67-73. doi: 10.1192/bjpo.bp.115.001073 |
|
2015 Conference Publication Reported Clozapine-Related Adverse Drug Reactions in Australia 1993-2013Siskind, D., Kolomensky, A., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Reported Clozapine-Related Adverse Drug Reactions in Australia 1993-2013. RANZCP 2015 Congress, Brisbane, QLD Australia, 3-7 May 2015. London, United Kingdom: Sage Publications. doi: 10.1177/0004867415578344 |
|
2015 Journal Article Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in NepalKhanal, Saval, Veerman, Lennert, Hollingworth, Samantha and Nissen, Lisa (2015). Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal. Perspective in Public Health, 135 (4), 177-178. doi: 10.1177/1757913915586654 |
|
2015 Conference Publication Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.Donges, E., Staatz, C. E. and Hollingworth, S. A. (2015). Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.. APSA-ASCEPT conference, Hobart, Australia, 29th November - 2nd December 2015. |
|
2015 Journal Article Clozapine in the community: improved access or risky free- for-allWinckel, Karl, Siskind, Dan, Hollingworth, Sam, Robinson, Gail, Mitchell, Scott, Varghese, Daniel, Smith, Lesley and Wheeler, Amanda (2015). Clozapine in the community: improved access or risky free- for-all. Australian and New Zealand Journal of Psychiatry, 49 (10), 863-865. doi: 10.1177/0004867415592957 |
|
2014 Journal Article Multiple sclerosis disease modifying medicine utilisation in AustraliaHollingworth, Samantha, Walker, Kimitra, Page, Andrew and Eadie, Mervyn (2014). Multiple sclerosis disease modifying medicine utilisation in Australia. Journal of Clinical Neuroscience, 21 (12), 2083-2087. doi: 10.1016/j.jocn.2014.05.034 |
|
2014 Conference Publication Shaping the future of clozapine: safety implications of increased useHollingworth, S., Forrester, V., Winckel, K., Wheeler, A. and Siskind, D. (2014). Shaping the future of clozapine: safety implications of increased use. National Medicines Symposium 2014, Brisbane, QLD Australia, 21 - 23 May 2014. |
